检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:杨帆[1] 马海涛[1] 朱建军[1] 黄海涛[1]
机构地区:[1]苏州大学附属第一医院胸心外科,江苏苏州215006
出 处:《世界肿瘤杂志》2007年第4期245-247,252,共4页Tumour Journal of the World
摘 要:目的研究非小细胞肺癌组织和支气管切缘环氧化酶.2(Cyclooxygenase,COX-2)活性表达的意义及其与预后的关系。方法应用RT-PCR技术检测80例非小细胞肺癌组织、支气管切缘(支气管切缘病理切片无癌组织残留)及12例肺部良性病变组织的COX.2活性。结果在80例肺癌组织中,COX-2活性表达为58.8%(47例),切缘COX-2活性表达为12.5%(10例)。10例肺良性病变组织中未发现COX-2阳性表达。癌组织COX-2活性与肺癌肿瘤大小、临床分期、病理分化程度、病理组织分型、淋巴结转移以及肿瘤部位显著相关。支气管切缘COX-2活性与肺癌肿瘤大小、临床分期及肿瘤部位有显著性相关。术后随访6mo-3a,共有9例残端复发,其中8例为支气管切缘COX-2活性阳性病人。结论COX-2活性表达与非小细胞肺癌发生、进展和预后有关,检测肺切缘COX-2活性可作为早期预测肺癌术后复发的重要依据。Objeetive To study the expression of COX-2 activity at resection margin of the bronchus and lung cancer tissues, and to predict cancer recurrence. Methods The expression of COX-2 activity at patients with non small-cell lung cancer and 10 patients with non-cancerous diseases by RT-PCR technique. Results The positive expression rates of COX-2 activity at resection margin of the bronchus and lung cancer tissues were 12.5% (10 cases) and 58.8% (47cases), respectively. Those of COX-2 activity in lung non-cancerous tissues were negative. The positive expression rates of COX-2 activity in cancer tissues correlated with tumor size, TNM stages, pathological differentiation level, histological typeing, lymphatic metastasis, and tumor location (P〈0.05). The positive expression of COX-2 activity at resection margin of the bronchus correlated with tumor size, TNM stages and tumor location (P〈0.05). During follow-up period (ranged 6 months to 3 years), 8 patients with COX-2 activity at resection margin had local recurrence. Conclusions The expression of COX-2 activity correlated with genesis, progression and prognosis of esophageal cancer. By testing COX-2 activity at resection margin of the bronchus, we may predict local recurrence of lung cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145